Channels The Economic Impact of Cumulative Metabolic Comorbidity Burden in Schizophrenia: A Claims-Based Analysis of Medical Costs in the United States
The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study
The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
Treatment of patients with comorbid pain syndromes: an effective and safe approach
Cardiovascular comorbidity in patients with restless legs syndrome: current perspectives
Two Hospitalized Cases of Major Depressive Episodes With Comorbidities and Psychosocial Stressors: Case Reports
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
An excitement building in the development of psychological treatments for schizophrenia
Chronic pain and mental disorders: a frequent comorbidity requiring a new comprehensive approach
Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
The new German evidence‐ and consensus‐based schizophrenia guideline
Temporal recalibration in schizophrenia: a compensatory timing trap?
Longitudinal study of PTSD and depression in a war-exposed sample – comorbidity increases distress and suicide risk
High Adherence to Pharmacological Treatment Guidelines in Recovery and Remission States Among Patients With Schizophrenia: A Cross‐Sectional Study
Real-World Effectiveness and Safety of Ofatumumab: Analysis of B Cell Depletion, Comorbidities and Ethnicity in a Spanish Cohort
Identification of Shared Genetic Variants and Haplotypes Associated With Schizophrenia and Depression
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
What does it take to make real‐world changes in schizophrenia care?
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
The Lived Experience of Cognitive Impairment Associated With Schizophrenia: A Conceptual Model
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
